Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Common Equity (2018 - 2025)

Exagen's Common Equity history spans 8 years, with the latest figure at $17.4 million for Q4 2025.

  • For Q4 2025, Common Equity rose 82.9% year-over-year to $17.4 million; the TTM value through Dec 2025 reached $17.4 million, up 82.9%, while the annual FY2025 figure was $17.4 million, 82.9% up from the prior year.
  • Common Equity reached $17.4 million in Q4 2025 per XGN's latest filing, down from $18.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $101.5 million in Q1 2021 to a low of $6.4 million in Q1 2025.
  • Average Common Equity over 5 years is $42.6 million, with a median of $29.7 million recorded in 2023.
  • Peak YoY movement for Common Equity: surged 104.17% in 2021, then crashed 67.97% in 2025.
  • A 5-year view of Common Equity shows it stood at $84.9 million in 2021, then crashed by 50.01% to $42.5 million in 2022, then crashed by 46.55% to $22.7 million in 2023, then crashed by 57.96% to $9.5 million in 2024, then skyrocketed by 82.9% to $17.4 million in 2025.
  • Per Business Quant, the three most recent readings for XGN's Common Equity are $17.4 million (Q4 2025), $18.1 million (Q3 2025), and $21.0 million (Q2 2025).